Merck (MRK) Times Interest Earned (2011 - 2013)
Merck (MRK) posted quarterly Times Interest Earned of -$13.09 for Q1 2013, down 49.75% YoY from -$26.05 in Q1 2012, and up 11.98% sequentially from -$14.87 in Q4 2012.
Merck (MRK) Times Interest Earned (2011 - 2013) Analysis & Trends
Merck has disclosed Times Interest Earned across 3 years of filings, most recently posting -$13.09 for Q1 2013.
- In Q1 2013, Times Interest Earned fell 49.75% year-over-year to -$13.09; the TTM figure through Dec 2013 stood at -$62.01 (down 475.24% YoY), while the FY2012 annual figure was $4.28, up 16.0% from the prior year.
- Times Interest Earned grew to -$13.09 in Q1 2013, from -$14.87 in the prior quarter.
- Over the last five years, Times Interest Earned for MRK reached as high as -$8.33 in Q2 2012 and fell as low as -$15.36 in Q2 2011.
- The 3-year median for Times Interest Earned is -$12.53 (2011), against an average of -$12.23.
- Annual changes were most pronounced in 2012 — Times Interest Earned jumped 45.81% — and 2013, when it slumped 49.75%.
- A 3-year view of Times Interest Earned shows it stood at -$15.0 in 2011, then climbed by 0.84% to -$14.87 in 2012, then advanced by 11.98% to -$13.09 in 2013.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$13.09, -$14.87, and -$10.78 for Q1 2013, Q4 2012, and Q3 2012 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 23.39 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -10.80 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -13.09 |
| Dec 31, 2012 | -14.87 |
| Sep 30, 2012 | -10.78 |
| Jun 30, 2012 | -8.33 |
| Mar 31, 2012 | -8.74 |
| Dec 31, 2011 | -15.00 |
| Sep 30, 2011 | -11.36 |
| Jun 30, 2011 | -15.36 |
| Mar 31, 2011 | -12.53 |